The Germany Bariatric Surgery Devices Marketwas valued at $97.4 Mn in 2023 and is projected to grow at a CAGR of 3.4% from 2023 to 2023, to $123 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Cook Medical, Intuitive Surgicals, Medtronic, B. Braun, Johnson & Johnson among others.
Germany CT Scan Market was valued at $168.73 Mn in 2023 and is predicted to grow at a CAGR of 6.07% from 2023 to 2030, to $254.88 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic diseases and the rising geriatric population, increasing technological advancements, rising awareness and early diagnosis focus, and integration of AI and machine learning. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
The Germany Cough Hypersensitivity Syndrome Therapeutics Market was valued at $296 Mn in 2022 and is predicted to grow at a CAGR of 4.1% from 2023 to 2030, to $409 Mn by 2030. The key drivers of this industry include the increasing prevalence of Cough Hypersensitivity Syndrome, expanding government initiatives, and high unmet medical needs. The industry is primarily dominated by players such as Roche, Pfizer, Teva, Novartis, Johnson & Johnson, and GSK among others.
The Germany Mental Health Apps Market was valued at $226.92 Mn in 2023 and is predicted to grow at a CAGR of 13.4% from 2023 to 2030, to $547.22 Mn by 2030. The key drivers of this industry include rising awareness, increasing smartphone penetration, and healthcare integration. The industry is primarily dominated by players such as MindShift CBT, Headspace, Calm, and 7 Cups among others.
The Germany Actinic Keratosis Therapeutic Market is expected to grow at a CAGR of 3.10%, rising from $249 Mn in the year 2022 reaching $318 Mn by the year 2030. The rising incidence of actinic keratosis, improvements in treatment options, rising public awareness and screening programs, encouraging government initiatives, technological advancements, an aging population, market competition, and patient preferences are the factors driving the Germany Actinic Keratosis Therapeutic Market. The key players in the Germany Actinic Keratosis Therapeutic Market include Bayer, Galderma, Pierre Fabre, Chemiplastics, Oncopharma, Aclaris Therapeutics, Varens, Photocure, Meda Pharma etc.
Germany Constipation Therapeutics Market was valued at $666 Mn in 2022 and is estimated to reach $962 Mn in 2030, exhibiting a CAGR of 4.7% during the forecast period. The constipation therapeutics market is experiencing growth driven by rising global rates of constipation associated with factors like aging, sedentary lifestyles, and poor dietary habits, as well as the expanding elderly population, which is particularly prone to chronic conditions. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Ipsen Pharma, Johnson & Johnson, Norgine Pharmaceuticals, Pierre Fabre Médicament, Recordati, and Sanofi.
Germany Brain Cancer Therapeutics Market valued at $84 Mn in 2022, projected to reach $165 Mn by 2030 with a 9.8% CAGR. The expected rise in incidents of brain cancer, specifically glioblastoma multiforme, is projected to significantly drive the demand for brain cancer therapeutics, influencing the overall market scenario. Leading pharmaceutical companies currently working in the market are Roche, Merck & Co., Bristol Myers Squibb, Novartis, Pfizer, AstraZeneca, Eli Lilly, Sanofi, Takeda Pharmaceutical, and AbbVie.
The Germany Herbal Supplements Market was valued at $192.52 Mn in 2023 and is predicted to grow at a CAGR of 4.4% from 2023 to 2030, to $260.24 Mn by 2030. The key drivers of this industry include the prevalence of chronic health conditions, increasing health consciousness, and rising usage of supplements. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, Botanic Supplements, and Bionorica among others.
The Germany Brugada Syndrome Market was valued at $43.9 Mn in 2023 and is predicted to grow at a CAGR of 6.0% from 2023 to 2030, to $66 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the Germany Brugada Syndrome Market are Bayer, Roche, Siemens Healthineers, Sanofi, Thermo Fisher Scientific, and Novartis, among others.
Germany Clinical Nutrition for Chronic Kidney Diseases Market was valued at $57.50 Mn in 2023 and is predicted to grow at a CAGR of 4.23% from 2023 to 2030, to $76.80 Mn by 2030. The key drivers of this industry include the high prevalence of CKD, increasing awareness and education, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Germany Dental Endodontics Market was valued at $64 Mn in 2023 and is predicted to grow at a CAGR of 2.5% from 2023 to 2030, to $76.10 Mn by 2030. The key drivers of this industry include a high focus on oral health, an aging population, and technological advancement. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The Germany Clinical Nutrition Market was valued at $1122.5 Mn in 2023 and is projected to grow at a CAGR of 3.54% from 2023 to 2023, to $1432 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Hipp, Norgine, Dr Schar, Abbott Nutrition, Nestle, Danone Nutricia among others.
Germany Digital Biomarkers Market was valued at $106.14 Mn in 2023 and is predicted to grow at a CAGR of 20.5% from 2023 to 2030, to $391.55 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and the focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
The Germany Biosensors Market was valued at $1057.7 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $1611.6 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, technological advancements, and growing demand for Point-of-Care (POC) testing. The prominent players of the Germany Biosensors Market are Lifesensors, Siemens Healthcare, B. Braun Melsungen AG, Meridian Bioscience, and Biosensors International, among others.
The Germany Physiotherapy Equipment Market was valued at $764.94 Mn in 2023 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $1,105.38 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are BTL Industries, EMS Physio, ITO Co. Ltd., and Enraf-Nonius B.V. among others.
Germany Cardiac Resynchronization Therapy Market valued at $176 Mn in 2022, projected to reach $226 Mn by 2030 with a 3.2% CAGR. The global rise in heart failure cases, driven by aging populations and lifestyle-related cardiovascular diseases, is a key factor contributing to the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, leading participants in this market include Abbott, Boston Scientific, Medtronic, Biotronik, Siemens Healthineers, St. Jude Medical, Sorin Group, Edwards Lifesciences, LivaNova, and Terumo.
The Germany Dental Consumables Market was valued at $1237.1 Mn in 2023 and is projected to grow at a CAGR of 6.2% from 2023 to 2023, to $1884.8 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to increasing urbanization, and changing living standards. The industry is primarily dominated by players such as DMG Dental, VOCO GmbH, Heraeus Kulzer, Dentsply Sirona, GC Corporation, 3M among others.
The Germany Medical Digital Imaging System Market was valued at $1116.3 Mn in 2023 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $1723.35 Mn by 2030. The key drivers of this industry include an aging population, healthcare infrastructure, and rising chronic disease. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Germany Hemodialysis Vascular Grafts Market was valued at $7.67 Bn in 2023 and is predicted to grow at a CAGR of 3.3% from 2023 to 2030, to $9.62 Bn by 2030. The key drivers of this industry include the rising prevalence of end-stage renal disease, government investment in healthcare, and technological advancements. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
The Germany Hospital Market was valued at $201.28 Bn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $298.68 Bn by 2030. The key drivers of this industry are government investment, aging population, and emphasis on innovation. The key players in the industry are Helios Kliniken, Asklepios Kliniken, Sana Kliniken, and University Hospital Dusseldorf among others.